Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 720 $ 423
Accounts receivable and contract assets, net of allowance for doubtful accounts of $34 million and $33 million, respectively 97 83
Income tax receivable 50 50
Other current assets 25 23
Total current assets 892 579
Property and equipment, net 126 132
Intangible assets not subject to amortization (note 6):    
Goodwill 2,230 2,240
Trademarks 731 732
Intangible assets not subject to amortization 2,961 2,972
Intangible assets subject to amortization, net 182 202
Other assets, at cost, net of accumulated amortization 197 201
Total assets 4,358 4,086
Current liabilities:    
Deferred merchant and other payables 84 54
Deferred revenue 38 28
Accrued liabilities and other current liabilities 186 160
Total current liabilities 308 242
Long-term debt, including $301 million measured at fair value (note 5) 1,173 532
Deferred income tax liabilities 147 180
Financial instrument liabilities (note 4) 339 14
Preferred stock liability (note 6) 199  
Other liabilities 337 339
Total liabilities 2,503 1,307
Redeemable preferred stock, $.01 par value. Authorized shares 50,000,000; issued and outstanding 198,079 shares at March 31, 2021 and 325,000 shares at December 31, 2020 (note 6) 472
Equity:    
Additional paid-in capital 289 257
Accumulated other comprehensive earnings (loss), net of taxes (21) (23)
Retained earnings (738) (278)
Total stockholders' equity (469) (43)
Noncontrolling interests in equity of subsidiaries 2,324 2,350
Total equity 1,855 2,307
Commitments and contingencies (note 8)
Total liabilities, redeemable preferred stock and equity 4,358 4,086
Series A    
Equity:    
Common stock value 1 1
Series B    
Equity:    
Common stock value
Series C    
Equity:    
Common stock value